Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$2.22B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$372M |
| 3 |
Danaher
DHR
|
+$293M |
| 4 |
Linde
LIN
|
+$281M |
| 5 |
Carlyle Group
CG
|
+$268M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$926M |
| 2 |
iShares Russell 1000 ETF
IWB
|
+$770M |
| 3 |
iShares Bitcoin Trust
IBIT
|
+$649M |
| 4 |
Meta Platforms (Facebook)
META
|
+$641M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$462M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 9% |
| 2 | Technology | 7.77% |
| 3 | Healthcare | 6.87% |
| 4 | Industrials | 5.57% |
| 5 | Consumer Discretionary | 5.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4426
PUT
Immunovant
IMVT
$7.93B
| $769K | ﹤0.01% |
+45,000
| New | +$941K |
|
|
SGMO
4427
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $769K | ﹤0.01% |
1,172,092
-1,567,574
| -57% | -$1.66M |
|
4428
Titan International
TWI
$466M
| $765K | ﹤0.01% |
91,174
+48,451
| +113% | +$401K |
|
4429
S&T Bancorp
STBA
$1.84B
| $765K | ﹤0.01% |
20,645
-12,250
| -37% | -$471K |
|
4430
Amplify Junior Silver Miners ETF
SILJ
$3.18B
| $764K | ﹤0.01% |
63,000
-130,500
| -67% | -$1.47M |
|
4431
CALL
Insmed
INSM
$21.4B
| $763K | ﹤0.01% |
10,000
-61,900
| -86% | -$4.73M |
|
4432
Werewolf Therapeutics
HOWL
$17.2M
| $763K | ﹤0.01% |
784,617
+188,328
| +32% | +$247K |
|
4433
Vanguard Total International Stock ETF
VXUS
$155B
| $762K | ﹤0.01% |
+12,278
| New | +$758K |
|
4434
PUT
Watsco Inc
WSO
$12.7B
| $762K | ﹤0.01% |
1,500
-5,600
| -79% | -$2.76M |
|
4435
PUT
Maplebear
CART
$10.5B
| $762K | ﹤0.01% |
19,100
-44,800
| -70% | -$1.99M |
|
4436
Vanguard Total International Bond ETF
BNDX
$81.9B
| $761K | ﹤0.01% |
15,580
-151
| -1% | -$7.38K |
|
|
NEXN
4437
Nexxen International
NEXN
$573M
| $760K | ﹤0.01% |
91,005
-7,737
| -8% | -$69.8K |
|
4438
Xtrackers USD High Yield Corporate Bond ETF
HYLB
$3.52B
| $758K | ﹤0.01% |
20,964
+12,583
| +150% | +$458K |
|
4439
CEVA Inc
CEVA
$910M
| $758K | ﹤0.01% |
29,587
-39,690
| -57% | -$1.28M |
|
4440
OceanFirst Financial
OCFC
$1.68B
| $756K | ﹤0.01% |
44,433
-116,404
| -72% | -$2.07M |
|
4441
CALL
Indivior Pharmaceuticals
INDV
$4.73B
| $756K | ﹤0.01% |
+79,300
| New | +$834K |
|
4442
PUT
Coupang
CPNG
$29.3B
| $752K | ﹤0.01% |
34,300
-68,000
| -66% | -$1.58M |
|
4443
CALL
ZIM Integrated Shipping Services
ZIM
$3.04B
| $751K | ﹤0.01% |
51,500
+25,700
| +100% | +$483K |
|
4444
CALL
Clorox
CLX
$11.6B
| $751K | ﹤0.01% |
5,100
-147,800
| -97% | -$22.6M |
|
|
GTLS
4445
CALL
DELISTED
Chart Industries
GTLS
| $751K | ﹤0.01% |
+5,200
| New | +$958K |
|
4446
Merchants Bancorp
MBIN
$2.53B
| $750K | ﹤0.01% |
20,282
-105,805
| -84% | -$4.17M |
|
4447
Caribou Biosciences
CRBU
$145M
| $750K | ﹤0.01% |
821,051
-38,774
| -5% | -$50.4K |
|
4448
Aquestive Therapeutics
AQST
$464M
| $749K | ﹤0.01% |
258,216
+170,989
| +196% | +$518K |
|
4449
Allot
ALLT
$372M
| $748K | ﹤0.01% |
131,075
+17,465
| +15% | +$122K |
|
|
AVDL
4450
DELISTED
Avadel Pharmaceuticals
AVDL
| $747K | ﹤0.01% |
95,378
-1,116,626
| -92% | -$9.35M |
|
Similar funds
Millennium Management's Q1 2025 Portfolio in Review
As of Q1 2025, Millennium Management held 6,639 positions worth $188B, down 8.2% from $205B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Millennium Management withdrew a net $8.86B in Q1 2025, closing 852 positions and reducing 2,261 holdings. Its most notable exit was Verizon, an estimated $263M position sold in full.
By sector, the portfolio is most concentrated in Financials at 9% of assets, up from 8.3% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Millennium Management opened a new position in Blackrock worth $215M.
- Millennium Management's largest Q1 2025 buy was Blackrock: 227,394 shares worth $215M.
- Millennium Management added most to iShares Core S&P 500 ETF in Q1 2025, an estimated $2.22B increase.
- Millennium Management's biggest Q1 2025 reduction was Broadcom, cutting an estimated $926M.
- Millennium Management fully exited Verizon in Q1 2025, selling an estimated $263M.
- Millennium Management's ten largest holdings make up 16% of its $188B portfolio in Q1 2025.
- Millennium Management opened 739 new positions and closed 852 in Q1 2025.
- Millennium Management's portfolio value fell 8.2% quarter-over-quarter to $188B.
Based on Millennium Management's 13F filing for Q1 2025, filed 15 May 2025.